Our profiling of plasma eccDNA from 16 Stage III‐IV PDAC patients and 19 healthy controls for the detection of cancer pathogenic SNP in eccDNA did not reveal any KRAS‐derived eccDNAs or eccDNAs with pathogenic variants in the samples from either group. The gene discussed is KRAS; the disease is cancer.